Stomach Neoplasms 
Welcome,         Profile    Billing    Logout  

8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stomach Neoplasms
CRITICS, NCT00407186 / 2006-004130-32: Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer

Active, not recruiting
3
788
Europe
cisplatin+capecitabine, radiotherapy, epirubicin+cisplatin+capecitabine
Dutch Colorectal Cancer Group, The Netherlands Cancer Institute, Roche Pharma AG
Gastric Cancer
12/18
12/25
NCT01815853: Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Recruiting
3
620
RoW
Neoadjuvant Chemoradiotherapy, Neoadjuvant Chemotherapy, R0 D2 Gastrectomy, Adjuvant Chemotherapy
Sun Yat-sen University, Guangdong Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University, Liaoning Cancer Hospital & Institute, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangxi Medical University Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Zhejiang Cancer Hospital, First Hospital of China Medical University, First People's Hospital of Hangzhou
Gastric Cancer
12/23
12/25
NCT01322542: YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome

Recruiting
2
30
US
YF476
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Carcinoid
12/17
12/17
NCT02209441: Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer

Available
1
RoW
Phase I Dose-finding Study of Sorafenib Study
Chinese Academy of Medical Sciences
Gastric Cancer.
 
 
CGCT-01, NCT02130752: Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery

Recruiting
N/A
430
RoW
Monopolar electrocautery, Ultrasonic scalpel
West China Hospital
Gastric Cancer, Surgery, Ultrasonic Scalpel, Monopolar Electrocautery, Operation Time, Blood Loss, Surgical, Quality of Life, External Causes of Morbidity and Mortality
10/19
10/22
NCT02313688: Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

Recruiting
N/A
320
RoW
gastrectomy
West China Hospital
Stomach Neoplasms, Siewert Type II Adenocarcinoma of Esophagogastric Junction, Recurrence, Siewert Type III Adenocarcinoma of Esophagogastric Junction
12/20
12/23
NCT01919242: Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study

Recruiting
N/A
10000
RoW
gastrectomy
Yonsei University
Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer
09/23
09/23
NCT02184910: Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea

Recruiting
N/A
108
RoW
pepsinogen and gastrin
Yonsei University
Atrophic Gastritis
12/23
12/23

Download Options